EUVIMEDEUVIMED entdecken
Crossref

Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the “gut-kidney axis”

Zhen Shen, Tao Cui, Yao Liu, Shuai Wu, Cong Han, Jie Li

Phytomedicine · 2023-12 · 121 · 155129

DOI: 10.1016/j.phymed.2023.155129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2023-12. Verfasst von Zhen Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shandong University of Traditional Chinese Medicine, No.4655 Daxue Road, Jinan 250014, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Salvia miltiorrhiza. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The combination of Astragalus membranaceus and Salvia miltiorrhiza (AS) is an effective prescription for treating diabetic kidney disease (DKD) in traditional Chinese medicine. Its efficacy in treating DKD has been confirmed, but the potential regulatory mechanism has not yet been fully clarified. PURPOSE: To explore the mechanism by which AS regulates the "gut-metabolism-transcription" coexpression network under the action of the "gut-kidney axis" to ameliorate DKD. METHODS: SD rats were used to establish the DKD model by injecting STZ. After AS intervention, the structure and function of the kidney and colon were observed. We sequenced the gut microbiota utilizing 16S rDNA, identified serum differential metabolites using LC‒MS/MS, and observed renal mRNA expression by RNA seq. The "gut-metabolism-transcription" coexpression network was further constructed, and the target bacteria, target metabolites, and target genes of AS were ultimately screened and validated. RESULTS: AS improved renal pathology and functional damage and increased the abundance of Akkermansia, Akkermansia_muciniphila, Lactobacillus and Lactobacillus_murinus. Fourteen target metabolites of AS were identified, which were mainly concentrated in 19 KEGG pathways, including sphingolipid metabolism and glycerophospholipid metabolism. Sixty-three target mRNAs of AS were identified. The top 20 pathways were closely related to glycolipid metabolism, and 14 differential mRNAs were expressed in these pathways. Correlation analysis showed that Akkermansia, Akkermansia muciniphila, Lactobacillus and Lactobacillus murinus were closely associated with sphingolipid metabolism, glycerophospholipid metabolism, arachidonic acid metabolism, ascorbate and aldarate metabolism and galactose metabolism. Moreover, the target metabolites and target mRNAs of AS were also enriched in five identical pathways of sphingolipid metabolism, glycerophospholipid metabolism, arachidonic acid metabolism, ascorbate and aldarate metabolism and galactose metabolism, including 8 different metabolites, such as sphingosine, and 5 different genes, such as Kng1. The 8 metabolites had high AUC prediction values, and the validation of the 5 genes was consistent with the sequencing results. CONCLUSION: Our research showed that AS can improve DKD via the "gut-kidney axis". Akkermansia muciniphila and Lactobacillus murinus were the main driving bacteria, and five pathways related to glycolipid metabolism, especially sphingolipid metabolism and glycerophospholipid metabolism, may be important follow-up reactions and regulatory mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesSalvia miltiorrhizaLactobacillusTandem Mass SpectrometryAstragalus propinquusRatsAkkermansiaKidneyGlycerophospholipidsRats, Sprague-DawleyArachidonic AcidGlycolipidsChromatography, LiquidSphingolipidsBacteriaAnimalsGalactose

Stichwörter der Autor:innen

16S rDNA sequencingAstragalus membranaceus and Salvia miltiorrhizaDiabetic kidney diseaseGut-kidney axisLC‒MS/MSRNA-seq

Substanzen

Arachidonic AcidGalactoseGlycolipidsGlycerophospholipidsSphingolipids

Autor:innen und Institutionen

  • Shandong University of Traditional Chinese Medicine, No.4655 Daxue Road, Jinan 250014, China.
  • Jinan Zhangqiu District Hospital of Traditional Chinese Medicine, Jinan 250200, China.
  • Nephropathy Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, No.16369 Jingshi Road, Jinan 250014, China.
  • Nephropathy Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, No.16369 Jingshi Road, Jinan 250014, China. Electronic address: hancong_kidney@hotmail.com.
  • Shandong University of Traditional Chinese Medicine, No.4655 Daxue Road, Jinan 250014, China. Electronic address: 13589099252@163.com.

Förderung

  • Shandong Province Natural Science Foundation
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Shen, Z., Cui, T., Liu, Y., Wu, S., Han, C., & Li, J. (2023). Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the “gut-kidney axis”. Phytomedicine, 121, 155129. https://doi.org/10.1016/j.phymed.2023.155129

Vancouver

Shen Z, Cui T, Liu Y, Wu S, Han C, Li J. Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the “gut-kidney axis”. Phytomedicine. 2023;121:155129. doi:10.1016/j.phymed.2023.155129

BibTeX
@article{Shen2023,
  author = {Shen, Zhen and Cui, Tao and Liu, Yao and Wu, Shuai and Han, Cong and Li, Jie},
  title = {Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the “gut-kidney axis”},
  journal = {Phytomedicine},
  year = {2023},
  volume = {121},
  pages = {155129},
  doi = {10.1016/j.phymed.2023.155129}
}
Kostenlos starten →